Search

Your search keyword '"Estrada, Vicente"' showing total 48 results

Search Constraints

Start Over You searched for: Author "Estrada, Vicente" Remove constraint Author: "Estrada, Vicente" Publisher elsevier bv Remove constraint Publisher: elsevier bv
48 results on '"Estrada, Vicente"'

Search Results

4. Clinical outcomes by supplemental oxygen use in remdesivir-treated, hospitalised adults with COVID-19

5. Expanding HIV clinical monitoring: the role of CD4, CD8, and CD4/CD8 ratio in predicting non-AIDS events

6. Monitoring monkeypox virus in saliva and air samples in Spain: a cross-sectional study

7. Monkeypox outbreak in Madrid (Spain): Clinical and virological aspects

8. Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial

9. Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial

11. Predictors of poor prognosis in healthy, young, individuals with SARS-CoV-2 infections

12. Renin-angiotensin system inhibitors effect before and during hospitalization in COVID-19 outcomes: Final analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry

13. Fibrilación auricular en pacientes con COVID-19. Utilidad de la puntuación CHA2DS2-VASc: un análisis del registro internacional HOPE COVID-19

14. Atrial fibrillation in patients with COVID-19. Usefulness of the CHA2DS2-VASc score: an analysis of the international HOPE COVID-19 registry

15. Does there exist an obesity paradox in COVID-19? Insights of the international HOPE-COVID-19-registry

16. Prevalence and 30-Day Mortality in Hospitalized Patients With Covid-19 and Prior Lung Diseases

17. Sepsis of Patients Infected by SARS-CoV-2: Real-World Experience from the International HOPE-COVID-19-Registry and Validation of HOPE Sepsis Score

18. Thalassemia Is Paradoxically Associated with a Reduced Risk of In-Hospital Complications and Mortality in COVID-19: Data from an International Registry

19. Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naïve Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)

20. Health Outcome Predictive Evaluation for COVID 19 international registry (HOPE COVID-19), rationale and design

21. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

22. CD4 recovery is associated with genetic variation in IFNγ and IL19 genes

24. Rate of cardiovascular, renal and bone disease and their major risks factors in HIV-infected individuals on antiretroviral therapy in Spain

25. Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2018)

28. Tenofovir alafenamide plus emtricitabine versus abacavir plus lamivudine for treatment of virologically suppressed HIV-1-infected adults: a randomised, double-blind, active-controlled, non-inferiority phase 3 trial

29. Costs and cost-efficacy analysis of the 2016 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults

31. Executive summary: Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015

32. Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015

33. Gut Bacteria Metabolism Impacts Immune Recovery in HIV-infected Individuals

34. Dual treatment with lopinavir–ritonavir plus lamivudine versus triple treatment with lopinavir–ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial

35. High prevalence at computed coronary tomography of non-calcified plaques in asymptomatic HIV patients treated with HAART: A meta-analysis

36. Resumen ejecutivo del documento de consenso sobre el manejo de la patología renal en pacientes con infección por el virus de la inmunodeficiencia humana

37. Documento de consenso: Recomendaciones para el manejo de la enfermedad ósea metabólica en pacientes con virus de la inmunodeficiencia humana

39. Vitamin D deficiency and vitamin D therapy in chronic hepatitis C

40. El ictus en pacientes muy ancianos: mitos y realidades

45. The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial

48. Thalassemia Is Paradoxically Associated with a Reduced Risk of In-Hospital Complications and Mortality in COVID-19: Data from an International Registry

Catalog

Books, media, physical & digital resources